Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma
Steven A. Miles(Cedars-Sinai Medical Center), Alvin E. Friedman‐Kien(California Department of Education), Jeannette Y. Lee(University of Arkansas at Little Rock), Lawrence D. Kaplan(UCSF Helen Diller Family Comprehensive Cancer Center), Jerome E. Groopman(Harvard University), Timothy P. Cooley(Memorial Sloan Kettering Cancer Center), David T. Scadden(Harvard University), Jamie Von Roenn(Northwestern University), M. Wayne Saville(California Department of Education), Bruce J. Dezube(Xilio Therapeutics (United States)), Mary A Fletcher(University of Miami), Susan E. Krown(Memorial Sloan Kettering Cancer Center)
Cited by 55
Related Papers
The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
|New England Journal of Medicine|1987|3k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition
|The Oncologist|2000|1.3k
The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
|New England Journal of Medicine|1987|1.2k